Loading
Life sciences · Journal article
BMC Complementary Medicine and Therapies · September 5, 2026
Raises a question worth testing. It does not answer one.
Two compounds from Piper crocatum showed in vitro inhibition of S. mutans and C. albicans growth and biofilm formation, with computational modelling suggesting binding to virulence factor enzymes GtfB and Sap5. This is early exploratory work in a laboratory setting; clinical relevance and efficacy remain unvalidated and require in vivo studies.
In vitro and in silico study. Two bioactive compounds isolated from Piper crocatum; tested against laboratory cultures of S. mutans and C. albicans using in vitro assays (antibacterial, antifungal, antibiofilm) and computational molecular docking and dynamics simulations.. Intervention: Two bioactive compounds from Piper crocatum.
Both compounds inhibited microbial growth and reduced biofilm formation in vitro. Computational analysis revealed strong binding affinities and stable interactions with GtfB. Dual targeting of GtfB and Sap5 suggests potential for dental caries prevention.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This work does not yet support clinical use. The findings are preliminary mechanistic observations that may inform future drug discovery but require controlled in vivo studies and clinical trials before any recommendation for caries prevention.
In vitro and computational study of natural compounds against oral pathogens; no clinical outcomes, no quantified inhibition data, and explicit call for in vivo validation limits this to exploratory mechanistic work.
As stated by the source record.
This work does not yet support clinical use. The findings are preliminary mechanistic observations that may inform future drug discovery but require controlled in vivo studies and clinical trials before any recommendation for caries prevention.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract Background Dental caries is a widespread infectious disease caused by complex interactions between microorganisms in oral biofilms. Streptococcus mutans plays a central role through acid production and glucan-mediated biofilm formation, while Candida albicans enhances biofilm stability and tissue damage. Their virulence factors, glucosyltransferase B (GtfB) and secreted aspartyl proteinase 5 (Sap5), are key molecular targets for therapeutic intervention. Natural compounds offer safer alternatives to synthetic antimicrobials in caries prevention. Methods Two bioactive compounds isolated from Piper crocatum were evaluated against S. mutans and C. albicans. In vitro assays included antibacterial, antifungal, and antibiofilm testing. In silico molecular docking and dynamics simulations were performed to examine compound interactions with GtfB and Sap5 enzymes. Results Both compounds inhibited microbial growth and reduced biofilm formation in vitro. Computational analysis revealed strong binding affinities and stable interactions with GtfB, supporting their potential to interfere with glucan-mediated adhesion and proteolytic activity. Conclusion The tested compounds demonstrated promising antibacterial, antifungal, and antibiofilm effects against S. mutans and C. albicans. Their dual targeting of GtfB and Sap5 highlights their potential as natural agents for dental caries prevention. Further in vivo studies are required to validate these findings.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.